Skip to main content
. Author manuscript; available in PMC: 2015 May 20.
Published in final edited form as: Bone Marrow Transplant. 2014 May 12;49(9):1139–1145. doi: 10.1038/bmt.2014.89

Figure 2. Probability of leukemia-free survival.

Figure 2

A indicates chemotherapy recipients after an early first relapse; B, transplant recipients with TBI regimens after an early first relapse; C, transplant recipients with non-TBI regimens after an early first relapse; D, chemotherapy recipients after late first relapse; E, transplant recipients with TBI regimens after late first relapse; and F, transplant recipients with non-TBI regimens after late first relapse.

From Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 2006; 107(12): 4961-7.